Joylux, a Seattle-based startup that markets products to support the health of menopausal women, raised $5.5 million. The new cash is part of a larger Series A round, bringing its total to $13 million.
The company’s vFit and vSculpt app-enabled devices are designed to improve vaginal health using red-light LEDs and gentle heat. The aim is to rebuild collagen and elastin and increase blood in the vaginal tissue to counteract bladder leakage and dryness, which can affect women in menopause, and improve sexual function.
Joylux devices and accessory products are carried by more than 1,000 retail and health partners, including Saks.com, Goop, and Neiman Marcus. The company also sells gels, creams, cooling pads and light therapy devices for the vagina, skin, breasts, hair and nails.
“Women want alternative treatment options to hormone replacement therapy, and we now have a platform of products that address a myriad of menopause health issues with non-hormonal solutions,” said CEO and founder Colette Courtion in a statement last week announcing the funding. Courtian, an entrepreneur and former Starbucks director with a background in medical aesthetics, founded Joylux in 2016.
The 13-person company will use the new funds to expand the growth of the vFit and vSculpt devices and associated products. Joylux plans to expand its product offerings in Latin America and Europe through a partnership with Essity, a consumer health and hygiene company.
“We believe the category of menopause can be a multi-billion-dollar opportunity,” said Essity global director of menopause Christine Arbelaez in the statement.
Another Seattle startup focused on women’s healthcare, Gennev, was acquired for an undisclosed sum by Unified Women’s Healthcare in October. Gennev, which launched as Genneve in 2016, provides telehealth services and products for women going through perimenopause and menopause.
Joylux’s new funds were raised from J-Ventures, J-Impact Kathy Fields, co-founder of skincare product company Rodan + Fields. Total funding to date is more than $20 million.